News

Deal Announcements

Predictive BioSciences Closes New Financing Round

Friday, October 17, 2008 5:54:00 AM PDT | VentureDeal Staff
Lexington, Massachusetts  --  Biotechnology company Predictive BioSciences has secured $21.75 million in its second institutional venture capital funding round.

Predictive is a molecular diagnostics company working on technologies in the areas of tumor growth, tumor angiogenesis and cancer markers.

New Enterprise Associates led the round, which included Kaiser Permanente Ventures, Flybridge Capital Partners and Highland Capital Partners. The company said it would use the funding proceeds to complete its current clinical studies and initiate multi-center clinical trials.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1